According to QY Research Medical, the single-use bioprocessing market was estimated at $7 billion in 2020, and is expected to surpass $38.8 billion by 2030, growing at a CAGR of 18.6% from 2021 to 2030.
According to QY Research Medical, the single-use bioprocessing market was estimated at $7 billion in 2020, and is expected to surpass $38.8 billion by 2030, growing at a CAGR of 18.6% from 2021 to 2030.
Single-use bioprocessing employs disposable technologies for the development and manufacturing of pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), personalized medicine, and others. The adoption of single-use bioprocessing products has witnessed significant increase during the developmental stages of drugs and manufacturing of several biopharmaceuticals. This product has revolutionized the upstream as well as downstream processes of manufacturing drugs making it faster, simpler, and cheaper. Factors that boost the growth of single-use bioprocessing market include surge in demand for biopharmaceuticals, rise in adoption of disposable technologies, low risk of product cross-contamination attributed to SUB technologies, and less floor space requirement. However, certain aspects such as extractability &leachability issues and stringent regulations pertaining to use of disposable systems in biopharmaceutical industry hamper the market growth.
Full Report is Ready | Request Sample of This Report @ https://qyresearchmedical.com/sample/112641
Single-use bioprocessing media bags & containers are used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the bio manufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb); hence, this segment has a leading share in the global single-use bioprocessing market.
The Single-use bioprocessing market size in this report is studied on the basis of product, application, method, end user, and region. On the basis of product, the market is divided by bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. By application, the market is divided into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. By method, the market is classified into filtration, storage, cell culture, mixing, and purification. On the basis of end user, the market is divided into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Scope of the Report
| Report Coverage | Details |
| Market Size in 2020 | $7 Billion |
| Revenue Forecast by 2030 | $38.8 Billion |
| CAGR | 18.6% from 2021 to 2030 |
| Base Year | 2021 |
| Forecast Data | 2022 to 2030 |
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112641/2900
Segment review
On the basis of product, the media bags & containers segment currently dominates the global single-use bioprocessing market and is expected to continue this trend during the forecast period owing to single-use bioprocessing media bags & containers used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the bio manufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb).
On the basis of method, the filtration segment dominated the global single-use bioprocessing market forecast in 2020 and is anticipated to be dominant in the market as it is a vital method to manufacture biological products such as vaccine, monoclonal antibodies, and others.
On the basis of application, the monoclonal antibody production segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market as monoclonal antibodies are immensely useful to treat various immune disorders and are an integral part of vaccine development.
On the basis of end user, the biopharmaceutical manufacturers segment dominated the global single-use bioprocessing market forecast in 2020 and is anticipated to be dominant in the market owing to increased adoption of these systems for enhanced production of vaccines, monoclonal antibodies, and personalized medicines.
Region Segment Review
Region wise, North America single-use bioprocessing market growth dominated the market in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada, and then unveiling it to the rest of the world. North America is known for its healthcare facilities and medical services. In addition, rise in the adoption of single-use bioprocessing technologies for various biopharmaceutical applications has propelled the growth of the market. However, Asia-Pacific single-use bioprocessing industry is expected to witness considerable market growth during the forecast period due to significant demand for bioprocess equipment including laboratory filtration systems and membrane-based microbial analysis among many others. In addition, Asia-Pacific witnessed strong growth in both the pharma and laboratory equipment market, which is expected to offer lucrative opportunities for single-use bioprocessing products in future. Moreover, India and China is expected to grow at high CAGR in Asia-Pacific single-use bioprocessing market.
The major companies profiled in this report include 3M Company, Cesco Bioengineering Co. Ltd., Danaher Corporation, Eppendorf AG., Corning, Inc., Getinge Group, Merck KGaA, PBS Biotech, Sartorius Stedim Biotech, and Thermo Fisher Scientific, Inc.
Key Benefits For Stakeholders
- This global single-use bioprocessing market size report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single-use bioprocessing market analysis from 2020 to 2030 to identify the prevailing single-use bioprocessing market opportunities.
- The global single-use bioprocessing market share research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the single-use bioprocessing market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global single-use bioprocessing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
- By Product
- Bioreactors
- Tangential-Flow Filtration Devices
- Depth Filters
- Disposable Filter Cartridges
- Media Bags And Containers
- Mixing Systems
- Tubing Assemblies
- Sampling Systems
- Others
- By Application
- Monoclonal Antibody Production
- Vaccine Production
- Plant Cell Cultivation
- Patient Specific Cell Therapies
- Others
- By Method
- Filtration
- Storage
- Cell Culture
- Mixing
- Purification
- By End User
- Biopharmaceutical Manufacturers
- Life Science R&D Companies & Academic Research
- Contract Research Organization & Manufacturers
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Turkey
- South Africa
- Rest of LAMEA
- North America
Key Market Players
- 3M Company
- Applikon Biotechnology
- Cesco Bioengineering C0. Ltd.
- Danaher Corporation
- eppendorfag
- Merck Milipore
- PBS
- Sartorius Stedim Biotech S.A
- Thermo Fisher Scienctific
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112641/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/